Executive Profile

Robert E. Flaherty Operating Partner, Behrman Capital

Age	Total Calculated Compensation	This person is connected to 5 Board Members in 5 different organizations across 10 different industries. See Board Relationships
66	--

Background

Mr. Robert E. Flaherty, Bob is an Operating Partner of Health Care Services at Behrman Capital. Mr. Flaherty joined Behrman Capital on May 15, 2009 and works with existing portfolio companies to build value as well as source and evaluate new acquisition platforms in the healthcare space for its continued growth. He has more than 35 years of operating experience in the healthcare field, with particular expertise in the clinical laboratory environment. Previously, Mr. ... Flaherty served as the Chief Executive Officer and President at Athena Diagnostics Inc., since 1992. From 1992 to 1995, Mr. Flaherty served as the Chief Executive Officer and President of Genica Pharmaceuticals Corporation, which was acquired by Athena Diagnostics in 1995. He also served as the President at Becton Dickinson Medical at Becton, Dickinson and Company from 1984 to 1992 and the President at Becton Dickinson Vacutainer Systems at Becton, Dickinson and Company from 1982 to 1984. Mr. Flaherty joined Becton Dickinson as a Marketing Director in 1976. Prior thereto, he held a series of product management, sales and marketing positions with CR Bard Inc. from 1971 to 1976. Mr. Flaherty began his career with Procter and Gamble Company in 1968 in manufacturing management. He serves as the Chairman of Atherotech, Inc. He served as the Chairman and Director of Athena Diagnostics Inc. since 1992. Mr. Flaherty has been a Director of XTENT, Inc. since January 2007. He serves as Director at USDS, Inc. He serves as a Director of Cantata Laboratories, Inc., Covenant Dove, LLC (a/k/a Ark Holdings) and Repromedix Inc. He served as a Member of Strategic Advisory Board at Mira Dx, Inc. He served as a Director of Angiodynamics Inc. from April 2004 to October 21, 2008. Mr. Flaherty served as a Director of Datatrak International Inc. from July 1998 to June 2, 2004. He serves on the Board of the Chernobyl Children’s Project. Mr. Flaherty holds a B.S. in Industrial Engineering from Lehigh University in 1968 and an M.B.A. from the Harvard Business School in 1971.

Corporate Headquarters 126 East 56th Street New York, New York 10022 United States Phone: 212-980-6500 Fax: 212-980-7024 Board Members Memberships Chairman of The Board Atherotech, Inc. Former Chief Executive Officer, President and Director Athena Diagnostics, Inc. Director Cantata Laboratories, Inc. Director Covenant Dove, LLC Director USDS, Inc. 1998-2004 Former Director DATATRAK International, Inc. 2004-2008 Former Director and Chairman of Compensation Committee AngioDynamics Inc. 2007-Present Director, Chairman of Compensation Committee and Member of Audit Committee XTENT, Inc. Education BS 1968 Lehigh University MBA 1971 Harvard Business School Other Affiliations Becton, Dickinson and Company Harvard University CR Bard Inc. DATATRAK International, Inc. Atherotech, Inc. Harvard Business School Athena Diagnostics, Inc. XTENT, Inc. Lehigh University AngioDynamics Inc. Cantata Laboratories, Inc. Covenant Dove, LLC Mira Dx, Inc. USDS, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.